IP Library Granted Patent US 7,498,345
Granted Patent B2
US 7,498,345 · App. 10/943,276 · Granted Mar 3, 2009

Process for production of piperidine derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,498,345
App. No.
10/943,276
Granted
Mar 3, 2009
Kind
B2
Abstract

Processes are disclosed for preparing piperidine derivative compounds of the formulae I, II or III: The processes involve reacting a compound of formula Ia, IIa or IIIa with isobutyrate or an isobutyrate equivalent.

Claims (58)

1. A process for preparing a piperidine derivative compound of formula I:

wherein

R 4 is selected from the group comprising H, alkyl, and aryl;

A, B, and D are the substituents of their rings, each of which may be different or the same, and are selected from the group consisting of hydrogen, fluorine, chlorine, alkyl, aryl, hydroxyl, alkoxy, and aryloxy;

said process comprising:

(a) reacting a compound of formula VIa

 wherein

 X is a group chosen from chlorine, bromine, iodine, —OSO 2 R 5 , and diazonium salt displaceable via oxidative metallic addition; and

 LG is a leaving group displaceable by a secondary amine, said leaving group chosen from chlorine, bromine, iodine, and —OSO 2 R 5 , wherein R 5 is chosen from alkyl, fluoroalkyl, aryl, and substituted aryl;

 with a piperidine compound of formula IX

 in the presence of a base to provide a compound of formula Ia

(b) reacting the compound of Ia with an isobutyrate equivalent of formula IV

 wherein R 8 is a trialkylsilyl,

 in the presence of a transition metal catalyst having a metal selected from the group comprising of Ni and Pd, and ZnF 2 to provide the compound of formula I.

2. A process according to claim 1 , wherein the compound of formula VIa is prepared by reacting a compound of formula Va

with a trialkylsilylhalide.

3. A process according to claim 1 for preparing fexofenadine wherein the compound of formula I is reacted in the presence of a reducing agent, and carrying out further process steps to provide fexofenadine.

4. A process according claim 1 wherein X is displaceable by the isobutyrate equivalent of formula IV by reaction in the presence of a phosphorous compound chosen from trialkyl phosphine, triaryl phosphine, and mixed alky/aryl phosphine, and the transition metal catalyst.

5. A process according to claim 1 wherein R 8 is trimethylsilyl.

6. A process according claim 1 for preparing fexofenadine comprising:

(a) reacting a compound of formula VIaa

 with a piperidine compound of formula IXaa

 in the presence of a base to provide a compound of formula Iaa

(b) reacting the compound of formula Iaa wth an isobutyrate equivalent of formula IVa

 in the presence of Pd(0) catalyst, a trialkyl or triaryl phosphine, and ZnF 2 to provide a compound of formula Iaaa

(c) and carrying out further processing steps to provide fexofenadine.

7. A process according to claim 6 wherein, the compound of VIaa is prepared by reacting a compound of formula Vaa

with a trimethlysilyliodide.

8. A process for preparing a piperidine derivative compound of formula II:

wherein

R 4 is selected from the group comprising H, alkyl, and aryl;

A, B, and D are the substituents of their rings, each of which may be different or the same, and are selected from the group consisting of hydrogen, fluorine, chlorine, alkyl, aryl, hydroxyl, alkoxy, and aryloxy;

said process comprising:

(a) reacting a compound of formula VIa

 wherein

 X is a group chosen from chlorine, bromine, iodine, —OSO 2 R 5 , and diazonium salt displaceable via oxidative metallic addition; and

 LG is a leaving group displaceable by a secondary amine, said leaving group chosen from chlorine, bromine, iodine, and —OSO 2 R 5 , wherein R 5 is chosen from alkyl, fluoroalkyl, aryl, and substituted aryl;

 with a piperidine compound of formula IX

 in the presence of a base to provide a compound of formula Ia

(b) reacting the compound of formula Ia with a reducing agent to provide a compound of formula IIa

(c) reacting the compound of IIa with an isobutyrate equivalent of formula IV

 wherein R 8 is a trialkylsilyl,

 in the presence of a transition metal catalyst having a metal selected from the group comprising of Ni and Pd, and ZnF 2 to provide the compound of formula II.

9. A process according to claim 8 , wherein the compound of formula VIa is prepared by reacting a compound of formula Va

with a trialkylsilylhalide.

10. A process according to claim 8 for preparing fexofenadine wherein the compound of formula II is reacted with a base, and carrying out further process steps to provide fexofenadine.

11. A process according claim 8 wherein X is displaceable by the isobutyrate equivalent of formula IV by reaction in the presence of a phosphorous compound chosen from trialkyl phosphine, triaryl phosphine, and mixed alkyl/aryl phosphine, and the transition metal catalyst.

12. A process according to claim 8 wherein R 8 is trimethylsilyl.

13. A process according claim 8 for preparing fexofenadine comprising:

(a) reacting a compound of formula VIaa

 with a piperidine compound of formula IXaa

 in the presence of a base to provide a compound of formula Iaa

(b) reacting the compound of formula Iaa with a reducing agent to provide a compound of formula IIaa

(c) reacting the compound of Iaa wth an isobutyrate equivalent of formula IVa

 in the presence of Pd(0) catalyst, a trialkyl or triaryl phosphine, and ZnF 2 to provide a compound of formula IIaaa

(d) and carrying out further processing steps to provide fexofenadine.

14. A process according to claim 13 wherein, the compound of VIaa is prepared by reacting a compound of formula Vaa

with a trimethlysilyliodide.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Jul 9, 2014
From: WELLS FARGO
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 033283/0357 →
SECURITY AGREEMENT Recorded Apr 20, 2012
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; AMRI BOTHELL RESEARCH CENTER, INC.; AMRI RENESSELAER, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 028078/0227 →
TERMINATION Recorded Apr 19, 2012
From: BANK OF AMERICA, N.A.
To: ALBANY MOLECULAR RESEARCH, INC.; AMRI BOTHELL RESEARCH CENTER, INC.; AMRI BURLINGTON, INC.; AMRI RENESSELAER, INC.
Reel/Frame 028072/0335 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jun 6, 2011
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI RENSSELAER, INC.; AMRI BOTHELL RESEARCH CENTER, INC.; AMRI BURLINGTON, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 026397/0001 →
MERGER Recorded Feb 8, 2010
From: AMR TECHNOLOGY, INC.
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 023905/0317 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2009
From: AMR TECHNOLOGY, INC.
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 022092/0512 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2005
From: MECKLER, HAROLD; LITTLER, BEN; RAJE, PRASAD; VAN BRUNT, MICHAEL; VOGT, PAUL F.
To: AMR TECHNOLOGY, INC.
Reel/Frame 016154/0520 →